1107254

Alnylam Pharmaceuticals, Inc. — FEI 3004080452

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 18, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Sponsor, Contract Research Organization